福元医药
(601089)
| 流通市值：32.32亿 | | | 总市值：75.55亿 |
| 流通股本：2.05亿 | | | 总股本：4.80亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,421,964,605.09 | 2,530,809,346 | 2,496,988,974.73 | 2,471,073,263.94 |
| 应收票据及应收账款 | 334,080,231.03 | 346,134,907.22 | 358,659,029.19 | 349,983,969.75 |
| 应收账款 | 334,080,231.03 | 346,134,907.22 | 358,659,029.19 | 349,983,969.75 |
| 应收款项融资 | 70,328,802.87 | 98,440,759.42 | 88,162,294.14 | 68,456,623.72 |
| 预付款项 | 46,259,419.61 | 41,698,624.51 | 29,259,127.65 | 33,518,907.6 |
| 其他应收款合计 | 2,393,585.98 | 1,792,213.18 | 3,607,197.28 | 4,026,265.01 |
| 存货 | 329,509,170.73 | 307,419,355.37 | 304,443,564.01 | 338,945,832.57 |
| 其他流动资产 | 2,884,977.95 | 2,445,359.11 | 4,490,100.83 | 3,441,950.04 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,207,420,793.26 | 3,328,740,564.81 | 3,285,610,287.83 | 3,269,446,812.63 |
| 非流动资产: | | | | |
| 固定资产 | 683,174,221.11 | 678,544,711.16 | 672,178,570.69 | 671,362,107.96 |
| 在建工程 | 286,144,341.53 | 255,657,249.32 | 212,727,186.37 | 139,186,045.83 |
| 使用权资产 | 44,839,498.26 | 49,209,809.36 | 54,637,163.72 | 59,150,287.78 |
| 无形资产 | 147,175,130.16 | 150,197,426.51 | 134,879,147.93 | 137,478,351.92 |
| 长期待摊费用 | 23,738,668.52 | 22,923,850.62 | 26,030,394.61 | 27,745,684.08 |
| 递延所得税资产 | 2,484,647.61 | 2,807,905.2 | 10,804,486.94 | 10,712,863.23 |
| 其他非流动资产 | 98,931,907.32 | 59,708,784.81 | 50,322,945.16 | 29,650,124.1 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,286,488,414.51 | 1,219,049,736.98 | 1,161,579,895.42 | 1,075,285,464.9 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,493,909,207.77 | 4,547,790,301.79 | 4,447,190,183.25 | 4,344,732,277.53 |
| 流动负债: | | | | |
| 短期借款 | 49,940,070 | 55,050,513.92 | 55,046,013.92 | 55,046,013.9 |
| 应付票据及应付账款 | 119,020,432.14 | 132,178,897.79 | 121,034,729.99 | 117,856,039.99 |
| 应付账款 | 119,020,432.14 | 132,178,897.79 | 121,034,729.99 | 117,856,039.99 |
| 预收款项 | 514,521.22 | 78,850 | - | - |
| 合同负债 | 64,780,124.77 | 39,743,326.9 | 31,732,720.31 | 50,277,422.63 |
| 应付职工薪酬 | 73,952,167.66 | 135,737,991.52 | 110,567,972.17 | 98,090,472.11 |
| 应交税费 | 36,241,886.14 | 42,990,787.03 | 48,377,617.02 | 38,788,224.69 |
| 其他应付款合计 | 565,125,331.5 | 537,491,861.57 | 572,966,903.78 | 603,779,913.12 |
| 一年内到期的非流动负债 | 22,804,723.24 | 24,612,808.6 | 22,496,087.36 | 22,830,004.41 |
| 其他流动负债 | 31,477,556.45 | 30,490,525.54 | 26,992,415.72 | 23,689,983.29 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 963,856,813.12 | 998,375,562.87 | 989,214,460.27 | 1,010,358,074.14 |
| 非流动负债: | | | | |
| 长期借款 | 12,372,611.02 | 12,373,544.87 | 14,846,144.43 | 14,847,105.75 |
| 租赁负债 | 27,787,169.66 | 32,262,214.12 | 38,470,068.64 | 43,324,003.93 |
| 递延收益 | 10,188,839.1 | 10,016,356.09 | 10,327,144.34 | 10,626,874.37 |
| 递延所得税负债 | 18,447,950.04 | 18,223,517.79 | 29,445,599.63 | 28,977,940.63 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 68,796,569.82 | 72,875,632.87 | 93,088,957.04 | 97,775,924.68 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,032,653,382.94 | 1,071,251,195.74 | 1,082,303,417.31 | 1,108,133,998.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 480,000,000 | 480,000,000 | 480,000,000 | 480,000,000 |
| 资本公积 | 1,662,392,718.51 | 1,662,392,718.51 | 1,662,392,718.51 | 1,662,392,718.51 |
| 减:库存股 | 148,626,645.16 | - | - | - |
| 专项储备 | 12,154,057.09 | 12,335,279.75 | 12,397,992.11 | 14,861,096.68 |
| 盈余公积 | 154,181,999.35 | 154,181,999.35 | 115,209,687.41 | 115,209,687.41 |
| 未分配利润 | 1,292,083,730.89 | 1,159,506,439.29 | 1,087,176,855.4 | 957,777,539.55 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,452,185,860.68 | 3,468,416,436.9 | 3,357,177,253.43 | 3,230,241,042.15 |
| 少数股东权益 | 9,069,964.15 | 8,122,669.15 | 7,709,512.51 | 6,357,236.56 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,461,255,824.83 | 3,476,539,106.05 | 3,364,886,765.94 | 3,236,598,278.71 |
| 负债和股东权益合计 | 4,493,909,207.77 | 4,547,790,301.79 | 4,447,190,183.25 | 4,344,732,277.53 |
| 公告日期 | 2024-04-24 | 2024-04-01 | 2023-10-27 | 2023-08-15 |
| 审计意见(境内) | | 标准无保留意见 | | |